China suspends vax doses following minor's death

China's Sinovac Biotech says that health officials in Beijing suspended the use of 83 doses of the inactivated hepatitis A vaccine Healive after a minor died two days after being vaccinated. Sinovac noted that out of the 19,850 doses distributed from the same lot of vaccines, no other adverse events had been recorded.

On November 29, regulators inspected Sinovac's manufacturing facility and reviewed its inspections and sales process without finding any irregularities, according to the company. Sinovac says it will continue to cooperate with the authorities and plans a follow-up report.

- check out the Sinovac release
- read RTTNews coverage

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.